The use of the Medanets app in psychiatric wards is increasing

In psychiatric hospital care, the primary measurement is not blood pressure or heart rate, but rather the patient’s behaviour, interaction and mood. The Medanets app supports healthcare professionals in documenting these observations and makes the data easily accessible.

While the Medanets app is a well-known tool on somatic wards, psychiatric wards are increasingly adopting it as well. On psychiatric wards, the app is used for documenting various types of information, such as:

  • Regular observations of the patient’s well-being and behaviour (e.g., BDI and MADRS questionnaires)
  • Assessments of functional capacity and risk factors, such as suicidal tendencies or violence (e.g., GAF-F and BVC assessments)
  • Medication administrations
  • Monitoring of vital signs, e.g., tracking medication effects
  • Tracking time spent outdoors, with notifications if the patient does not return at the agreed time
  • Special circumstances, such as drug screenings and restrictive measures.

Efficiency and consistency in documentation

In psychiatric care, documentation is often descriptive, with lengthy texts being typed on a computer. However, many of our customers utilise mobile forms with predefined response options to assess mood, interaction and risk behaviours. These forms can be tailored based on clinical evaluation criteria, or unit-specific practices. Pre-made forms streamline documentation, support consistent observations and simplify data comparison across different stages of the care process.

In addition to documentation, quick and easy access to patient information on mobile adds significant value to care processes. Healthcare professionals can quickly check on the app whether the patient has received their medication, when their last follow-up visit was, or whether the patient has any special risk factors that they should be aware of before entering the room. Up-to-date information supports timely clinical decisions – right at the point of care.

Share the Post:

Subscribe to our Newsletter